Science Explorer Back to mapMap
Discussion
Company · London · Canada

Mediprobe Research (Canada)

In research, Mediprobe Research (Canada) stands highest in Health Sciences (#3,545 of 16,688 worldwide) and Medicine (#4,883 of 14,558 worldwide), over all time.

mediproberesearch.caROR OpenAlex
World rank, all time
#22,168
of 34,923
Rank in Canada
#444
of 718
Research works
189
▲ 27% vs 2018-21
Citations
5.5k
28.8 per fractional work
Top-10% rate
34.2%
all institutions 10.0%
vs its own fields
1.37×
1.00× is exactly expected
Open access
25%
world 40%
International
30%
world 18%
Mediprobe Research (Canada)

What is Mediprobe Research (Canada) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #3,545 of 16,688 25.4%145
MedicineField #4,883 of 14,558 25.9%140

Each strip is that field's whole ranked pool, with the notch where Mediprobe Research (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Mediprobe Research (Canada) work in?

In 2022-now, 77% of research at Mediprobe Research (Canada) is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (76%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (4%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 44 fractional works · 77.1% of its workMedicine: 44 fractional works · 75.9% of its workEpidemiology: 16 fractional works · 28.2% of its workDermatology: 10 fractional works · 17.9% of its workUrology: 8 fractional works · 13.2% of its workInfectious Diseases: 2 fractional works · 3.8% of its workReproductive Medicine: 1 fractional works · 2.0% of its workPathology and Forensic Medicine: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.5% of its workRheumatology: 1 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.3% of its workRehabilitation: 0 fractional works · 0.6% of its workOncology: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.8% of its workHealth Professions: 0 fractional works · 0.8% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 11 fractional works · 19.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 12.1% of its workCell Biology: 5 fractional works · 9.1% of its workMolecular Biology: 1 fractional works · 2.3% of its workBiophysics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 2 fractional works · 3.6% of its workImmunology: 2 fractional works · 2.8% of its workVirology: 1 fractional works · 0.9% of its workAgricultural and Biological Sciences: 1 fractional works · 1.9% of its workPlant Science: 1 fractional works · 1.2% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workInsect Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.5% of its workPharmacology: 1 fractional works · 1.0% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 2.0% of its workSocial Sciences: 1 fractional works · 1.1% of its workHealth: 0 fractional works · 0.8% of its workSociology and Political Science: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.8% of its workDecision Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 1.0% of its workEngineering: 1 fractional works · 0.9% of its workBuilding and Construction: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.1% of its workALL ITS WORKMediprobeResearch (Canada)58fractional works, 2022-now
Life Sciences20%Physical Sciences1%Health Sciences77%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine4475.9%
    2. Health Professions00.8%
    3. Dentistry00.3%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology712.1%
    2. Immunology and Microbiology23.6%
    3. Agricultural and Biological Sciences11.9%
    4. Pharmacology, Toxicology and Pharmaceutics11.5%
    5. Neuroscience00.8%
    1. Social Sciences11.1%
    2. Psychology00.8%
    3. Decision Sciences00.1%
    1. Engineering10.9%
    2. Chemistry00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.39× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.26× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 3.62× its world share, 2 worksImmunology and Micro…Neuroscience: 0.51× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.16× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.07× its world share, 0 worksChemistryEngineering: 0.06× its world share, 0 worksEngineeringDentistry: 0.54× its world share, 0 worksDentistryHealth Professions: 0.30× its world share, 0 worksHealth ProfessionsMedicine: 3.95× its world share, 44 worksMedicineVeterinary: 0.71× its world share, 0 worksVeterinaryDecision Sciences: 0.15× its world share, 0 worksDecision SciencesPsychology: 0.25× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.2×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics4.16×1 works
  2. Medicine3.95×44 works
  3. Immunology and Microbiology3.62×2 works
  4. Biochemistry, Genetics and Molecular Biology2.26×7 works
  5. Veterinary0.71×0 works
  6. Dentistry0.54×0 works
  7. Neuroscience0.51×0 works
  8. Agricultural and Biological Sciences0.39×1 works
  9. Health Professions0.30×0 works
  10. Psychology0.25×0 works
  11. Decision Sciences0.15×0 works
  12. Social Sciences0.09×1 works
  13. Chemistry0.07×0 works
  14. Engineering0.06×0 works

Who are the top researchers at Mediprobe Research (Canada)?

Ranked on the quality score, Vasiliki Economopoulos, Mesbah Talukder and Mary A. Bamimore lead among researchers whose main affiliation is Mediprobe Research (Canada).

  1. 1 Vasiliki Economopoulos Canada · #412,716 worldwide 530 citations · 53 works
  2. 2 Mesbah Talukder Canada · #445,930 worldwide 1.8k citations · 113 works
  3. 3 Mary A. Bamimore Canada · #637,301 worldwide 1.3k citations · 83 works
  4. 4 Shruthi Polla Ravi Canada · #707,450 worldwide 714 citations · 39 works
  5. 5 Wayne L. Bakotic Canada · #710,281 worldwide 296 citations · 22 works
  6. 6 Tong Wang Canada · #784,845 worldwide 1.4k citations · 130 works
  7. 7 Kelly A. Foley Canada · #975,406 worldwide 2.5k citations · 78 works
  8. 8 Maanasa Venkataraman Canada · #990,915 worldwide 1.7k citations · 74 works
  9. 9 Rachel R. Mays Canada · #1,250,306 worldwide 987 citations · 32 works
  10. 10 Avantika Mann Canada · #1,524,998 worldwide 197 citations · 24 works
All ranked researchers at Mediprobe Research (Canada)

What are the most cited papers from Mediprobe Research (Canada)?

The most cited paper from Mediprobe Research (Canada) is "The treatment of melasma: A review of clinical trials" (Aditya Kumar Gupta, Melissa D. Gover, Keyvan Nouri et al., 2006), with 473 citations. Next come "Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders" (371) and "Update in Antifungal Therapy of Dermatophytosis" (331).

Most cited papers
#PaperReleasedCitations
1 The treatment of melasma: A review of clinical trials Aditya Kumar Gupta, Melissa D. Gover, Keyvan Nouri et al. · Journal of the American Academy of Dermatology 29 Sep 2006 473
2 Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders Madhulika A. Gupta, Aditya Kumar Gupta · American Journal of Clinical Dermatology 2003 371
3 Update in Antifungal Therapy of Dermatophytosis Aditya Kumar Gupta, Elizabeth A. Cooper · Mycopathologia 13 May 2008 331
4 Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version Ricardo Niklas Werner et al. · Journal of the European Academy of Dermatology and Venereology 14 Sep 2015 300
5 Onychomycosis: a review Aditya Kumar Gupta, Nadia Stec, Richard C. Summerbell et al. · Journal of the European Academy of Dermatology and Venereology 2 Apr 2020 288
All 59 most cited papers, with filters and sorting

Which keywords describe research at Mediprobe Research (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Diagnosis, Dermatophytes, Onychomycosis, Fungal Pathogens, Regeneration and Stem Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology17▲ 7.6×18 topics
  2. Antifungal Therapy17▲ 329×3 topics
  3. Diagnosis11▲ 21×4 topics
  4. Dermatophytes10▲ 696×1 topic
  5. Onychomycosis10▲ 696×1 topic
  6. Fungal Pathogens10▲ 126×2 topics
  7. Regeneration8▲ 67×4 topics
  8. Stem Cells7▲ 47×4 topics
  9. Epidermal Niche7▲ 638×1 topic
  10. Hair Follicle7▲ 638×1 topic
  11. Cryptococcal Disease5▲ 348×1 topic
  12. Histoplasmosis5▲ 348×1 topic
  13. Molecular Identification4▲ 111×2 topics
  14. Endophytic Fungi4▲ 78×1 topic
  15. Phylogenetic Analysis4▲ 23×1 topic
  16. Inflammation4▲ 3.0×8 topics
  17. Pathogenesis3▲ 11×4 topics
  18. Filaggrin3▲ 109×1 topic
  19. Skin Microbiome3▲ 109×1 topic
  20. Photodynamic Therapy3▲ 23×2 topics
  21. Treatment3▲ 3.7×3 topics
  22. Acne Vulgaris2▲ 219×1 topic
  23. Rosacea2▲ 219×1 topic
  24. Metabolic Syndrome2▲ 4.9×4 topics
  25. Immunosuppressive Therapy2▲ 16×3 topics
  26. Wound Healing2▲ 11×5 topics
  27. Cosmetic Surgery2▲ 70×2 topics
  28. Autoantibodies1▲ 10×4 topics
  29. Candidiasis1▲ 52×1 topic
  30. Invasive Fungal Infections1▲ 64×1 topic
  31. Complications1▲ 4.7×2 topics
  32. Dermal Fillers1▲ 96×1 topic
  33. Hyaluronic Acid1▲ 96×1 topic
  34. Autoimmune1▲ 46×2 topics
  35. Ovarian Reserve1▲ 45×1 topic
  36. Pemphigoid1▲ 75×1 topic
  37. Polycystic Ovary Syndrome1▲ 45×1 topic
  38. Rituximab1▲ 13×1 topic
  39. Cutaneous Lymphomas1▲ 95×1 topic
  40. Mycosis Fungoides1▲ 95×1 topic

Which research topics does Mediprobe Research (Canada) publish most on?

By volume in 2022-now: Nail Diseases and Treatments, Hair Growth and Disorders, Fungal Infections and Studies and Plant Pathogens and Fungal Diseases.

Nail Diseases and Treatm…10Nail Diseases and Treatments: 10 fractional worksHair Growth and Disorders: 7 fractional worksFungal Infections and Studies: 5 fractional worksPlant Pathogens and Fungal Diseases: 4 fractional worksDermatology and Skin Diseases: 3 fractional worksAcne and Rosacea Treatme…2Acne and Rosacea Treatments and Effects: 2 fractional worksAntifungal resistance and susceptibility: 1 fractional worksFacial Rejuvenation and Surgery Techniques: 1 fractional worksOvarian function and disorders: 1 fractional worksAutoimmune Bullous Skin Diseases: 1 fractional works
EpidemiologyUrologyCell BiologyDermatology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nail Diseases and Treatments Epidemiology 10 works
  2. 2 Hair Growth and Disorders Urology 7 works
  3. 3 Fungal Infections and Studies Epidemiology 5 works
  4. 4 Plant Pathogens and Fungal Diseases Cell Biology 4 works
  5. 5 Dermatology and Skin Diseases Dermatology 3 works
  6. 6 Acne and Rosacea Treatments and Effects Dermatology 2 works
  7. 7 Antifungal resistance and susceptibility Infectious Diseases 1 works
  8. 8 Facial Rejuvenation and Surgery Techniques Dermatology 1 works
  9. 9 Ovarian function and disorders Reproductive Medicine 1 works
  10. 10 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.9%not open75.1%

World: 40% of research is openly available.

with international co-authors30.2%domestic only69.8%

World: 18% is written across borders.

How has Mediprobe Research (Canada)'s research output changed?

Output in 2022-2025 was 27% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mediprobe Research (Canada) as a percentage of every work published that year, 0.00028% in 2024.

still counting0.00020%0.00040%0.00060%Mediprobe Research (Canada)0.00027% in 2025200020102020

Fractional works of Mediprobe Research (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in London

All research institutions in London

Share Mediprobe Research (Canada)'s ranking

Mediprobe Research (Canada) on Science Explorer

A card with Mediprobe Research (Canada)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mediprobe Research (Canada). Posts are plain text and can be reported.